| Tekturna Information from Drugs.com Tekturna (aliskiren) is used to treat high blood pressure (hypertension). Includes Tekturna side effects, interactions and indications. Read More |
| Novartis Pharmaceuticals Corporation UPDATED April 19, 2012: Tekturna (aliskiren) tablets and Aliskiren-Based Products Information Center. Please see important information about Tekturna and aliskiren ... Read More |
| Tekturna Official FDA information, side effects and uses. Accurate, FDA approved Tekturna information for healthcare professionals and patients - brought to you by Drugs.com. Read More |
| Tekturna - (Aliskiren) Side Effects, Dosage, Uses, Interaction ... Tekturna is used to treat high blood pressure. Learn about Tekturna from the publishers of the Physicians Desk Reference. You should not take this medication if you ... Read More |
| Tekturna (Aliskiren Tablets) Drug Information: Description, User ... Learn about the prescription medication Tekturna (Aliskiren Tablets), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Aliskiren - Wikipedia, the free encyclopedia Aliskiren (INN) (trade names Tekturna , U.S.; Rasilez , U.K. and elsewhere) is the first in a class of drugs called direct renin inhibitors . Its current licensed ... Read More |
| Novartis announces termination of ALTITUDE study with Rasilez ... Novartis announces termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment Read More |
| Aliskiren - PubMed Health - National Center for Biotechnology ... Notice. This MedWatch affects the following medications: Amturnide (aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide) Tekturna ... Read More |
| Tekturna®, Tekturna HCT® Discount Coupon - Get Group Rate ... Download a reusable buying group coupon for Valturna and get group rate savings on your next Valturna prescription. InternetDrugCoupons.com - More MANUFACTURER Drug ... Read More |
| Novartis ends Tekturna trial on safety concerns - FiercePharma Bad news for Novartis' blood pressure med Tekturna (aka Rasilez). The drug company has decided to end a trial evaluating the med in Type 2 diabetes patients with ... Read More |
